Submitted by Anonymous (not verified) on 6 October 2026 - 16:30
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 19, Status: Authorised